LoginSignup
CV

CapsoVision, Inc.

Stock
Stock
ISIN: US1409351079
Ticker: CV
US1409351079
CV

Price

Price

CHART BY

Frequently asked questions

What is CapsoVision, Inc.'s market capitalization?

The market capitalization of CapsoVision, Inc. is $183.82M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What are the analyst ratings and target price for CapsoVision, Inc.'s stock?

Currently, 2 analysts cover CapsoVision, Inc.'s stock, with a consensus target price of $5.50. Analyst ratings provide insights into the stock's expected performance.

What is the free float of CapsoVision, Inc.'s shares?

The free float of CapsoVision, Inc. is 27.98M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$183.82M
Free Float 
27.98M

Pricing

52W span
$3.49$5.72

Analyst Ratings

The price target is $5.50 and the stock is covered by 2 analysts.

Buy

2

Hold

0

Sell

0

Information

CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.

Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US1409351079
Primary Ticker
CV
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin